Sharon Elad

Summary

Country: Israel

Publications

  1. doi Topical immunomodulators for management of oral mucosal conditions, a systematic review; Part II: miscellaneous agents
    Sharon Elad
    Hebrew University Hadassah School of Dental Medicine, Department of Oral Medicine, POB 12272, Jerusalem 91120, Israel
    Expert Opin Emerg Drugs 16:183-202. 2011
  2. doi Topical immunomodulators for management of oral mucosal conditions, a systematic review; part I: calcineurin inhibitors
    Sharon Elad
    Hebrew University Hadassah School of Dental Medicine, Department of Oral Medicine, POB 12272, Jerusalem 91120, Israel
    Expert Opin Emerg Drugs 15:713-26. 2010
  3. doi Validation of the National Institutes of Health (NIH) scale for oral chronic graft-versus-host disease (cGVHD)
    Sharon Elad
    Department of Oral Medicine, Hebrew University, Hadassah School of Dental Medicine, Jerusalem, Israel
    Biol Blood Marrow Transplant 16:62-9. 2010
  4. doi A randomized controlled trial of visible-light therapy for the prevention of oral mucositis
    Sharon Elad
    Department of Oral Medicine, Hebrew University Hadassah School of Dental Medicine, Jerusalem, Israel
    Oral Oncol 47:125-30. 2011
  5. doi Dental treatment for high-risk patients with refractory heart failure: a retrospective observational comparison study
    Mordechai Findler
    Department of Hospital Oral Medicine, Hebrew University Hadassah School of Dental Medicine, Jerusalem, Israel
    Quintessence Int 44:61-70. 2013
  6. doi Improvement in oral chronic graft-versus-host disease with the administration of effervescent tablets of topical budesonide-an open, randomized, multicenter study
    Sharon Elad
    Department of Oral Medicine, Hebrew University Hadassah School of Dental Medicine, Jerusalem, Israel
    Biol Blood Marrow Transplant 18:134-40. 2012
  7. ncbi The antimicrobial effect of Iseganan HCl oral solution in patients receiving stomatotoxic chemotherapy: analysis from a multicenter, double-blind, placebo-controlled, randomized, phase III clinical trial
    Sharon Elad
    Department of Oral Medicine, Hebrew University Hadassah School of Dental Medicine, Jerusalem, Israel
    J Oral Pathol Med 41:229-34. 2012
  8. ncbi Survey of acceptance of the 2007 American Heart Association guidelines for the prevention of infective endocarditis: a pilot study
    Sharon Elad
    Department of Oral Medicine, Hadassah School of Dental Medicine, Hebrew University, Jerusalem, Israel
    Quintessence Int 42:243-51. 2011
  9. doi Exceptional oral manifestations of amyloid light chain protein (AL) systemic amyloidosis
    Sharon Elad
    Department of Oral Medicine, Hebrew University Hadassah School of Dental Medicine, Jerusalem, Israel
    Amyloid 17:27-31. 2010
  10. doi A systematic review of viral infections associated with oral involvement in cancer patients: a spotlight on Herpesviridea
    Sharon Elad
    Department of Oral Medicine, Hebrew University, Hadassah School of Dental Medicine, Jerusalem, Israel
    Support Care Cancer 18:993-1006. 2010

Detail Information

Publications15

  1. doi Topical immunomodulators for management of oral mucosal conditions, a systematic review; Part II: miscellaneous agents
    Sharon Elad
    Hebrew University Hadassah School of Dental Medicine, Department of Oral Medicine, POB 12272, Jerusalem 91120, Israel
    Expert Opin Emerg Drugs 16:183-202. 2011
    ....
  2. doi Topical immunomodulators for management of oral mucosal conditions, a systematic review; part I: calcineurin inhibitors
    Sharon Elad
    Hebrew University Hadassah School of Dental Medicine, Department of Oral Medicine, POB 12272, Jerusalem 91120, Israel
    Expert Opin Emerg Drugs 15:713-26. 2010
    ....
  3. doi Validation of the National Institutes of Health (NIH) scale for oral chronic graft-versus-host disease (cGVHD)
    Sharon Elad
    Department of Oral Medicine, Hebrew University, Hadassah School of Dental Medicine, Jerusalem, Israel
    Biol Blood Marrow Transplant 16:62-9. 2010
    ..Analysis of categoric parameters suggests that the NIH scale disproportionately differentiates between moderate-erythema/ulceration and severe-lichenoid cGVHD...
  4. doi A randomized controlled trial of visible-light therapy for the prevention of oral mucositis
    Sharon Elad
    Department of Oral Medicine, Hebrew University Hadassah School of Dental Medicine, Jerusalem, Israel
    Oral Oncol 47:125-30. 2011
    ..These findings suggest that the VLT-device is safe and effective for the prevention of oral mucositis in patients undergoing HSCT...
  5. doi Dental treatment for high-risk patients with refractory heart failure: a retrospective observational comparison study
    Mordechai Findler
    Department of Hospital Oral Medicine, Hebrew University Hadassah School of Dental Medicine, Jerusalem, Israel
    Quintessence Int 44:61-70. 2013
    ..The changes have significant implications for the medical management of the disease, as well as on the ability to provide proper dental treatment for these patients...
  6. doi Improvement in oral chronic graft-versus-host disease with the administration of effervescent tablets of topical budesonide-an open, randomized, multicenter study
    Sharon Elad
    Department of Oral Medicine, Hebrew University Hadassah School of Dental Medicine, Jerusalem, Israel
    Biol Blood Marrow Transplant 18:134-40. 2012
    ..The response was similar in all treatment arms. Safety analysis supported a dosing schedule of 3 mg of budesonide 3 times a day for 10 minutes...
  7. ncbi The antimicrobial effect of Iseganan HCl oral solution in patients receiving stomatotoxic chemotherapy: analysis from a multicenter, double-blind, placebo-controlled, randomized, phase III clinical trial
    Sharon Elad
    Department of Oral Medicine, Hebrew University Hadassah School of Dental Medicine, Jerusalem, Israel
    J Oral Pathol Med 41:229-34. 2012
    ..These complications prompted us to assess the antimicrobial activity of a topical Iseganan HCl mouthwash vs. placebo on the aerobic and facultatively anaerobic oral flora in these patients...
  8. ncbi Survey of acceptance of the 2007 American Heart Association guidelines for the prevention of infective endocarditis: a pilot study
    Sharon Elad
    Department of Oral Medicine, Hadassah School of Dental Medicine, Hebrew University, Jerusalem, Israel
    Quintessence Int 42:243-51. 2011
    ..To evaluate the acceptance rate of the 2007 American Heart Association (AHA) prophylactic protocol by the patients for whom the need for prophylaxis for infective endocarditis was downgraded...
  9. doi Exceptional oral manifestations of amyloid light chain protein (AL) systemic amyloidosis
    Sharon Elad
    Department of Oral Medicine, Hebrew University Hadassah School of Dental Medicine, Jerusalem, Israel
    Amyloid 17:27-31. 2010
    ..Since these oral manifestations can contribute to the diagnosis of systemic amyloidosis, clinicians should be made aware of them. Future research should assess the significance of oral manifestation as a prognostic indicator...
  10. doi A systematic review of viral infections associated with oral involvement in cancer patients: a spotlight on Herpesviridea
    Sharon Elad
    Department of Oral Medicine, Hebrew University, Hadassah School of Dental Medicine, Jerusalem, Israel
    Support Care Cancer 18:993-1006. 2010
    ..Quality of life (QOL) and economic impact were assessed if available in the articles reviewed...
  11. doi Cytotoxic chemotherapy-induced odontalgia: a differential diagnosis for dental pain
    Yehuda Zadik
    Department of Oral Medicine, Hebrew University Hadassah School of Dental Medicine, Jerusalem, Israel
    J Endod 36:1588-92. 2010
    ..Currently, localized pulpal pain is not listed as a possible complication of cytotoxic therapy. The aim of this report was to suggest cytotoxic-induced neurotoxicity as a differential diagnosis for toothache during anti-cancer therapy...
  12. ncbi A new management approach for dental treatment after a cerebrovascular event: a comparative retrospective study
    Sharon Elad
    Department of Oral Medicine, Hebrew University Hadassah School of Dental Medicine, Jerusalem, Israel
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod 110:145-50. 2010
    ..The purpose of this study was to suggest that the importance of dental care during this period exceeds the risk of medical complications in this patient population...
  13. doi Post-autologous stem cell transplantation administration of rituximab improves the outcome of patients with aggressive B cell non-Hodgkin's lymphoma
    Panagiotis Tsirigotis
    Department of Bone Marrow Transplantation and Cancer Immunotherapy, Hadassah Hebrew University Medical Center, P O Box 12000, Jerusalem 91120, Israel
    Ann Hematol 89:263-72. 2010
    ..We consider that the results of our study are promising but need to be verified within large randomized trials...
  14. doi Bisphosphonate-related osteonecrosis of the jaw: clinical correlations with computerized tomography presentation
    Sharon Elad
    Department of Oral Medicine, Hebrew University Hadassah School of Dental Medicine, Jerusalem, Israel
    Clin Oral Investig 14:43-50. 2010
    ..A large lesion on CT should raise the index of suspicion for sequestrum. The CT appearance of a continuous cortex of the mandibular canal may serve as a differential parameter between BRONJ and metastasis to the jaw...
  15. ncbi Oral effects of nonmyeloablative stem cell transplantation: a prospective observational study
    Sharon Elad
    Deparment of Medicine, Hebrew University Hadassah School of Dental Medicine, Jerusalem, Israel
    Quintessence Int 39:673-8. 2008
    ..The goal of the study was to evaluate the oral mucosal effects, including oral acute graft versus host disease (aGVHD), in patients undergoing NST in comparison to patients undergoing myeloablative HSCT...